RBH-61

N/A

Report date: 2021/11/26 17:52:17
NME

Base Information

Drug NameRBH-61
Drug Alias Namedual soluble epoxide hydrolase/phosphodiesterase inhibitorsRBH-61
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpoxide hydratase inhibitorsPhosphoric diester hydrolases inhibitors
TargetsEpoxide hydratasePhosphoric diester hydrolases
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California Davis
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A